AVROBIO Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Selling, General & Admin	23.97	33.25	35.73	32.99	20.84	11.15	3.2	1.96
Research & Development	47.7	72.19	83.11	87.24	54.97	35.1	15.19	2.66
Other Operating Expenses	-81.86	0	0	0	0	0	0	0
Operating Expenses	-10.19	105.43	118.84	120.23	75.81	46.24	18.39	4.63
Operating Income	10.19	-105.43	-118.84	-120.23	-75.81	-46.24	-18.39	-4.63
Interest Expense / Income	-2.42	0.3	0.22	0.72	0	0	0	0
Other Expense / Income	0.08	0.16	0.06	-1.24	-2.84	0.12	0.26	0.04
Pretax Income	12.53	-105.89	-119.13	-119.71	-72.97	-46.36	-18.65	-4.66
Income Tax	0.38	0	0	0	0	0	0	0
Net Income	12.16	-105.89	-119.13	-119.71	-72.97	-46.36	-18.65	-4.66
Preferred Dividends	0	0	0	0	0	2.24	0.09	0.31
Net Income Common	12.16	-105.89	-119.13	-119.71	-72.97	-48.6	-18.73	-4.97
Shares Outstanding (Basic)	44	44	43	36	27	13	2	2
Shares Outstanding (Diluted)	45	44	43	36	27	13	2	2
Shares Change	1.90%	2.07%	18.36%	31.98%	104.18%	500.91%	9.71%	-
EPS (Basic)	0.27	-2.42	-2.78	-3.31	-2.66	-3.62	-8.38	-2.44
EPS (Diluted)	0.27	-2.42	-2.78	-3.31	-2.66	-3.62	-8.38	-2.44
Free Cash Flow	-61.85	-97.48	-100.49	-99.98	-69.25	-39.48	-16.77	-3.31
Free Cash Flow Per Share	-1.40	-2.23	-2.35	-2.76	-2.52	-2.94	-7.50	-1.63
Effective Tax Rate	3.01%	-	-	-	-	-	-	-
EBITDA	12.64	-101.43	-117.5	-117.79	-72.12	-45.98	-18.6	-4.66
Depreciation & Amortization	2.53	4.17	1.4	1.21	0.85	0.38	0.05	0
EBIT	10.11	-105.59	-118.9	-118.99	-72.97	-46.36	-18.65	-4.66

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).